Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Penno

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
The Lancet. Diabetes & Endocrinology|October 21, 2023
Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERYMonia Garofolo, Giuseppe Penno
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 8, 2013
Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptinEleonora Russo, Giuseppe Penno, Stefano Del Prato
Diabetes Care|April 29, 2011
Multidrug treatment of type 2 diabetes: a challenge for complianceRoberto Miccoli, Giuseppe Penno, Stefano Del Prato
Diabetes Care|October 31, 2009
Changing the treatment paradigm for type 2 diabetesStefano Del Prato, Giuseppe Penno, Roberto Miccoli
Expert Review of Cardiovascular Therapy|November 27, 2007
Doxazosin in metabolically complicated hypertensionGiulia Dell'Omo, Giuseppe Penno, Stefano Del Prato, et al.
Aging|April 23, 2014
Optimal therapy of type 2 diabetes: a controversial challengeAngela Dardano, Giuseppe Penno, Stefano Del Prato, et al.
Herz|May 15, 2010
Blood glucose control and coronary heart diseaseCristina Bianchi, Giuseppe Penno, Roberto Miccoli, et al.
Diabetes Care|February 15, 2008
Primary prevention of cardiovascular disease in people with dysglycemiaCristina Bianchi, Roberto Miccoli, Giuseppe Penno, et al.
Pharmacological Research|May 23, 2006
The metabolic syndrome. Beyond the insulin resistance syndromeGiuseppe Penno, Roberto Miccoli, Laura Pucci, et al.
Atherosclerosis|August 22, 2008
Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: Cross-sectional findingsCristina Bianchi, Giuseppe Penno, Stefano Del Prato, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
The Lancet. Diabetes & Endocrinology|October 21, 2023
Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERYMonia Garofolo, Giuseppe Penno
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 8, 2013
Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptinEleonora Russo, Giuseppe Penno, Stefano Del Prato
Diabetes Care|April 29, 2011
Multidrug treatment of type 2 diabetes: a challenge for complianceRoberto Miccoli, Giuseppe Penno, Stefano Del Prato
Diabetes Care|October 31, 2009
Changing the treatment paradigm for type 2 diabetesStefano Del Prato, Giuseppe Penno, Roberto Miccoli
Expert Review of Cardiovascular Therapy|November 27, 2007
Doxazosin in metabolically complicated hypertensionGiulia Dell'Omo, Giuseppe Penno, Stefano Del Prato, et al.
Aging|April 23, 2014
Optimal therapy of type 2 diabetes: a controversial challengeAngela Dardano, Giuseppe Penno, Stefano Del Prato, et al.
Herz|May 15, 2010
Blood glucose control and coronary heart diseaseCristina Bianchi, Giuseppe Penno, Roberto Miccoli, et al.
Diabetes Care|February 15, 2008
Primary prevention of cardiovascular disease in people with dysglycemiaCristina Bianchi, Roberto Miccoli, Giuseppe Penno, et al.
Pharmacological Research|May 23, 2006
The metabolic syndrome. Beyond the insulin resistance syndromeGiuseppe Penno, Roberto Miccoli, Laura Pucci, et al.
Atherosclerosis|August 22, 2008
Serum gamma-glutamyltransferase is not associated to peripheral arterial disease in type 2 diabetic patients: Cross-sectional findingsCristina Bianchi, Giuseppe Penno, Stefano Del Prato, et al.
Pageof 12